Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736657 · ClinicalTrials.gov registry record · NA
Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients
A NA study, sponsored by Terumo BCT.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT01736657 is a NA study that has completed, run by Terumo BCT. The registered enrollment target is 73 participants.
The verdict
NCT01736657, a NA study, has completed, sponsored by Terumo BCT.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the performance of the Spectra Optia system red blood cell exchange (RBCx) protocols (exchange and depletion/exchange) in study participants with sickle cell disease.
Interventions
- DEVICE Red blood cell exchange in sickle cell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01736657
The ClinicalTrials.gov registry entry for NCT01736657 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Terumo BCT, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Red blood cell exchange in sickle cell is the first listed.
NCT01736657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01736657 about?
NCT01736657 is a clinical study titled "Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients". The purpose of this study is to evaluate the performance of the Spectra Optia system red blood cell exchange (RBCx) protocols (exchange and depletion/exchange) in study participants with sickle cell disease.
What is the current status of trial NCT01736657?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2012-11. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01736657?
The interventions under investigation include: Red blood cell exchange in sickle cell (DEVICE).
Who is sponsoring clinical trial NCT01736657?
This trial is sponsored by Terumo BCT, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.